Profile of patients with axial spondyloarthritis in Latin America: first report from the ESPALDA-PANLAR registry
Authors:
- Fernando SommerfleckFSFernando Sommerfleck
- Rodrigo Garcia-SalinasRGRodrigo Garcia-Salinas
- Diego VilaDVDiego Vila
- Daniel PalleiroDPDaniel Palleiro
- Daniel G. Fernández-ÁvilaDFDaniel G. Fernández-Ávila
- Julio César Casasola-VargasJCJulio César Casasola-Vargas
- Yelena Sanchez-CantoYSYelena Sanchez-Canto
- Liliana CandiaLCLiliana Candia
- Nicolás Marín ZúcaroNZNicolás Marín Zúcaro
- Maria Lorena BranceMBMaria Lorena Brance
- Lilith StangeLSLilith Stange
- Joan Manuel DapeñaJDJoan Manuel Dapeña
- 16 September 2025
- journal article
- research article
- Published by Springer Nature in Rheumatology International
- Vol. 45 (10) , 1-9
Abstract
Despite increasing recognition of axial spondyloarthritis (axSpA) in Latin America, regional data remain scarce. This study aims to describe the clinical, laboratory, and imaging features of axSpA in Latin America using data from the ESPALDA-PANLAR registry. A cross-sectional analysis was conducted using baseline data from the ESPALDA registry, which includes patients with axSpA across seven Latin American countries. Demographic, clinical, laboratory, and imaging data were collected. Patients were stratified by sex, HLA-B27 status, and radiographic classification. Multivariable logistic regression was performed to identify independent associations. A total of 220 patients were included (56% male), with a mean age of 46 years and median diagnostic delay of 93 months (IQR: 13–122). HLA-B27 was positive in 60% of patients, and 62% met radiographic axSpA classification criteria. In multivariable analysis, radiographic axSpA was independently associated with male sex (OR 4.22; 95% CI 1.53–11.59), SI joint erosions on MRI (OR 3.98; 95% CI 1.45–10.90), and longer diagnostic delay (OR 1.01 per month; 95% CI 1.00–1.01). HLA-B27 positivity was associated with bone marrow edema on MRI (OR 2.81; 95% CI 1.50–5.26) and inversely with psoriasis (OR 0.14; 95% CI 0.06–0.33). This first report from the ESPALDA registry highlights distinctive features of axSpA in Latin America, including lower HLA-B27 prevalence and remarkably diagnostic delay. These findings underscore the need for earlier recognition and regionally adapted strategies for diagnosis and management.Keywords
This publication has 47 references indexed in Scilit:
- Axial SpondyloarthritisJAMA, 2025
- Living with axial spondyloarthritis: a cross-sectional survey of patient knowledge and perceptionsRheumatology International, 2024
- Diagnosis, monitoring, and management of axial spondyloarthritisRheumatology International, 2024
- Prevalence of axial spondyloarthritis in Colombia: data from the National Health Registry 2017–2021Clinical Rheumatology, 2023
- Diagnostic delay in axial spondyloarthritis: a systematic reviewClinical Rheumatology, 2022
- Engagement process for patients with spondyloarthritis: PANLAR early SpA clinics project — centers of excellenceClinical Rheumatology, 2021
- Current status of the rheumatologists’ workforce in Latin America: a PANLAR collaborative studyClinical Rheumatology, 2021
- Analysis and performance of various classification criteria sets in a Colombian cohort of patients with spondyloarthritisClinical Rheumatology, 2016
- Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS‐G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ‐S)Arthritis Care & Research, 2011
- Evaluation of Diagnostic Criteria for Ankylosing SpondylitisArthritis & Rheumatism, 1984